Malaria infects more than 230 million people every year, and drug-resistant strains are rising. To stop this deadly endemic, researchers need new diagnostics—current tests are not sensitive enough to detect new strains or require expensive laboratory set-ups. Kiran has a solution. He’s developing a method that amplifies the genetic material of malaria so that it can be sequenced using 1/500th of the usual amount of required DNA. Unlike conventional techniques, Kiran’s method requires no special equipment, making it especially useful in remote, resource-limited areas. Kiran will use his BroadIgnite funds to hone this new technology and test its effectiveness on various strains of malaria. His hope is to develop a new frontline diagnostic test to aid malaria surveillance efforts in Africa.